Background: Asthma is a disease characterized by ventilation heterogeneity (VH). A number of studies have demonstrated that VH markers derived by using impulse oscillometry (IOS) or multiple-breath washout (MBW) are associated with key asthmatic patient-related outcome measures and airways hyperresponsiveness. However, the topographical mechanisms of VH in the lung remain poorly understood. Objectives: We hypothesized that specific regionalization of topographical small-airway disease would best account for IOSand MBW-measured indices in patients. Methods: We evaluated the results of paired expiratory/ inspiratory computed tomography in a cohort of asthmatic (n 5 41) and healthy (n 5 11) volunteers to understand the determinants of clinical VH indices commonly reported by
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Key words: Asthma, computed tomography, parametric response mapping, imaging, visualization, small-airways physiology, biomarker Asthma is characterized by spatial heterogeneity in disease and consequent heterogeneity in airways function and lung ventilation. 1, 2 Ventilation heterogeneity (VH) can be captured by using imaging approaches that can quantify and regionalize lung ventilation, such as hyperpolarized helium-3/xenon-129 magnetic resonance imaging (MRI), oxygen-enhanced magnetic resonance, and single-photon emission computed tomography (CT). [3] [4] [5] [6] [7] Additionally, VH can be measured clinically in patients by using physiologic tidal breathing techniques that measure heterogeneities in lung ventilation (captured by using multiple-breath washout [MBW]) 8, 9 and mechanical behavior (captured by using impulse oscillometry [IOS]). 10 International guidelines for quality control and assurance of tidal breathing markers of VH derived from IOS and MBW have been proposed, 11, 12 supporting their potential role as tools to study early airways disease.
We have previously identified that 2 specific markers of VH, resistance at 5 Hz minus resistance at 20 Hz measured by using impulse oscillometry (R5-R20) and acinar VH (S acin ; measured by using phase 3 slope analysis of multiple-breath washout data), derived from IOS and MBW, respectively, are associated with impaired asthma control, quality of life, and 9, 13 These observations have been replicated by other groups in parallel studies of adult asthma. 14, 15 Additionally, using computational small-airway models and diffusion MRI, we have previously demonstrated that IOS-derived R5-R20 and MBW-derived S acin values are anatomically grounded measures of small and acinar airway anatomic disease, respectively, in adult asthmatic patients. 9 Heterogeneity of ventilation within the lungs is likely to be influenced by both gravitational effects and airway branching, as well as other factors that affect regional lung compliance. 16 However, little is known about the spatial lung determinants of clinical measurements of VH derived by using MBW and IOS. This is important because imaging tools are costly and difficult to implement in clinical trials and standardize across centers; physiologic tools, if appropriately validated, could serve as simple surrogates of disease heterogeneity captured by using sensitive imaging techniques.
CT of the lungs has been exploited widely to study lung structure and function relationships in asthmatic patients. 17, 18 More recently, image registration applied to inspiratory and expiratory CT imaging has been used to derive indices of functional small-airways disease (fSAD). [19] [20] [21] [22] One specific and widely deployed approach is parametric response mapping (PRM). [20] [21] [22] The PRM approach offers the potential to characterize spatial deformation of a voxel between different acquired CT lung volumes, such as functional residual capacity (FRC) and total lung capacity (TLC), over the entire lung and hence the potential to identify spatial mechanisms of commonly measured MBW and IOS VH markers.
The purpose of this study was to use a range of global and regional airway density change (from FRC to TLC) imaging biomarkers to understand how spatial variations in VH can contribute to widely reported clinical measurements of VH and small-airways disease captured by IOS and MBW in adult asthmatic patients. Specifically, we hypothesized that abnormal regional variations in Hounsfield units (HU [DHU]) would be a major contributor to abnormal IOS-and MBW-derived physiologic indices of VH in the small airways and sought to test this hypothesis using a functional CT imaging and computational simulation study.
METHODS Subjects
The total population for this study consisted of 52 subjects, 41 adult asthmatic patients and 11 healthy control subjects. Asthmatic patients were recruited from Glenfield Hospital, Leicester, United Kingdom.
Asthma was defined by a clinician's diagnosis with 1 or more of the following objective criteria: (1) bronchodilator reversibility of FEV 1 to 400 mg of inhaled salbutamol of 12% and 200 mL or greater (17/41 asthmatic patients), (2) methacholine PC 20 of 16 mg/mL or less (11/41 asthmatic patients), or (3) peak flow variation of 20% or greater over a 2-week period (13/41 asthmatic patients).
Asthma severity was classified according to current Global Initiative for Asthma (GINA) treatment steps. 23 Patients with severe asthma within the cohort had similar lung function (postbronchodilator FEV 1 /forced vital capacity [FVC] ratio) to previously reported severe asthma cohorts in Leicester, United Kingdom, 24 but greater average postbronchodilator FEV 1 percent predicted values.
Age-matched healthy volunteers were recruited through local advertising and staff, with normal airway physiology and no features of respiratory disease. All asthmatic patients had been free from exacerbations for at least 6 weeks before study entry.
All subjects (both asthmatic patients and healthy volunteers) were noncurrent smokers; however, because of the known association of smoking and small-airways disease, pack year smoking exposure was not an exclusion criterion. Only 3 of 41 patients with asthma had a smoking history of more than 15 pack years.
Ethical approval
The study protocol was approved by the National Research Ethics Committee-East Midlands Leicester (approval no. 08/H0406/189), and all subjects provided written informed consent.
Visits
Clinical and physiologic assessment was performed in the following sequence and over 1 to 2 study visits no more than 1 week apart. Asthma control was characterized by using the modified 6-item Juniper Asthma Control Questionnaire, 25 and asthma quality of life was characterized by using the standard 32-question Juniper Asthma Quality of Life Questionnaire. 26 Exacerbations were defined according to American Thoracic Society (ATS)/European Respiratory Society (ERS) consensus criteria. 27 A moderate-to-severe exacerbation is defined as 1 or more of the following: (1) worsening of asthma that requires use of systemic steroids or an increase in systemic steroid use (for patients already receiving maintenance oral steroids) for 3 or more days or (2) an admission to the hospital or an emergency department requiring systemic steroids.
Lung function measurements
All lung function tests were performed after administration of 400 mg of inhaled salbutamol. Spirometry was performed according to ATS/ERS standards. 28 IOS was performed in triplicate, as previously reported, and in accordance with international guidelines. 11, 12 MBW was performed according to current guidelines 12 by using the sulfur hexafluoride (SF 6 ) wash-in method, as previously described. 13 SF 6 was chosen as the inert tracer gas because of its heavy molar mass and based on previous simulation data from Dutrieue et al, 29 suggesting that phase III slope sensitivity to SF 6 is maximal at the level of the alveolar duct. The phase III slope indices S cond (conductive zone VH) and S acin (acinar zone VH) were calculated by using custom software written with Test-Point (Measurement Computing, Norton, Mass), as previously described. 9, 13 Body plethysmography was performed with a constant-volume plethysmograph, according to the ATS/ERS recommendation. 30 A minimum of 3 acceptable tests were performed, and the test ended when the repeatability criterion was achieved (FRC within 10% between the highest and lowest values). Carbon monoxide uptake in the lung was determined by using the single-breath method, according to standard guidelines. 31 Alveolar volume and the carbon monoxide transfer coefficient were calculated.
CT imaging and image analysis
Volumetric whole-lung scans were obtained after administration of 400 mg of inhaled salbutamol at FRC and TLC in patients lying supine. CT images were quantified by using a panel of imaging biomarkers (see Table E1 in this article's Online Repository at www.jacionline.org).
PRM was performed automatically by using Imbio's Lung Density Analysis (LDA) software application (Imbio, Minneapolis, Minn) for all CT data, with registrations performed from TLC to FRC on segmented voxel sets, excluding the major airways (up to 3-4 generations from the trachea). Details on PRM analysis have been reported previously. [19] [20] [21] [22] Relative lung volumes of normal parenchyma (PRM Norm ), patients with fSAD (PRM fSAD ), patients with emphysema (PRM Emph ), and unclassified parenchyma (PRM Uncl ) were calculated by normalizing the sum of all like-classed voxels by total lung volume. Additionally, features of the PRM joint density histogram (ellipse area, minor axis, major axis, and angle to horizontal) were derived in MATLAB 2015a (MATLAB Release 2015a; MathWorks, Natick, Mass; Fig 1, A) .
A novel algorithm for evaluating regional density change gradients in a given direction, termed stratified axial analysis (SAA), was developed from per-voxel TLC to FRC density change (DHU; see Figs E1 and E2, A, in this article's Online Repository at www.jacionline.org). This allowed us to investigate how ventilation, approximated by DHU, varied with respect to axes of interest, particularly anterior-posterior (approximately parallel to gravity) and inferior-superior (approximately perpendicular to gravity; Fig 2, C and D). Straight-line fitting by using the ordinary least-squares criterion was applied to produce std(DHU) AP , DHU AP , std(DHU) IS , and DHU IS as the gradients of fitted lines to SAA-derived intervals (see Fig E1) , where AP and IS refer to the axis used (anterior-to-posterior and inferior-to-superior, respectively), std refers to SD, and x refers to the arithmetic mean of x. DHU ISÃ was calculated as the mean of DHU values across every decile, equivalent to the scaled (1:9) difference of extreme interval averages in the inferiorsuperior direction. Additional markers classifying lung size asymmetry were also derived by using custom scripts in MATLAB (see Fig E2, B) .
Computational simulations of regionalized bronchoconstriction
A detailed outline of the computational models is provided in the Methods section in this article's Online Repository at www.jacionline.org. Briefly, a computational model of airway impedance was designed based on previous models in the literature to provide simulations of IOS-derived R5-R20. In short, a 1-dimensional wave equation was used to estimate the impedance of each branch, 32 with total impedance being calculated through summation of parallel and series contributions. 33 Each terminal bronchiole was subtended by using a constant-phase viscoelastic model parameterized by using data from the literature. 34 Models were adjusted for potential confounding by upper airway shunting. 35, 36 Simulations of total lung resistance over the frequency range (1-25 Hz) were performed on the healthy conducting airway tree created through a combination of CT segmentation (to an average generation of 6) and algorithmic generation (to an average generation of 16), as previously reported. 37 For each simulation, constrictions were applied to either the lowest or highest 25% of small airways (< _2 mm in diameter) relative to the supine or orthostatic position to simulate the effects of gravitationally dependent airways. Constriction rates (percentage reduction in airway denoted as c) were drawn uniformly from the range (0% to 70%) and applied homogeneously by using the same c value for all airways or heterogeneously by drawing each constriction from the normal distribution with mean c value and SD of 0.2c. For each simulation, the output R5-R20 value was calculated.
Statistical analysis
Statistical analyses were performed in MATLAB 2015a. Kolmogorov-Smirnov tests were applied to check the likelihood of a normal distribution. Binary group comparisons were performed by using a 2-sample t test (parametric data) and Mann-Whitney U test (nonparametric data); for multiple-group comparisons, 1-way ANOVA (parametric data) and the Kruskal-Wallis test (nonparametric data) were used. Multiple-comparison procedures were performed with the Tukey honest significant difference criterion. Subgroups were determined based on GINA treatment steps and according to mean S acin and R5-R20 values. Sixteen subjects (roughly one third of the total population) at each end of R5-R20 and S acin distributions were used in tertile polar analysis at SAA inferior-superior deciles, where statistical significance was determined by using the 2-sided Wilcoxon rank sum test.
The average Pearson correlation coefficient (r) is reported for simple linear correlations. CT biomarker sets were defined by using Kaiser-Rule-determined principal component analysis and used for linear regression analyses to evaluate correlation with clinical traits and physiology. Linear discriminant analysis (LDA) was applied to determine class separation of the VH markers S acin and R5-R20 by using combinations of CT imaging features, clinical features, and spirometry. Negative binomial regression was used to evaluate the relationship between exacerbations and imaging biomarkers and Pearson correlations for association between asthma control/quality of life and imaging ventilation gradient biomarkers.
A P value of less than .05 was used to define statistically significant results in all tests.
RESULTS
Clinical characteristics of the population are outlined in Table I . Asthmatic patients were matched for age and sex to healthy volunteers. The asthmatic population had significantly greater eosinophilic airway inflammation and physiologic evidence of airway dysfunction and VH when compared with healthy volunteers. C, It can be seen that in the supine posture the inferior-superior lung density profile will be largely independent of gravity (transverse cross-section of expiratory HU voxels), with expected largest volume of ventilation in the lower lobes caused by the lower lobe having the largest proportionate lung volume. D, In contrast, the anterior-posterior lung density profile will be predominantly influenced by gravity (coronal cross-section of expiratory HU voxels), such that posterior ventilation will be proportionately lower than anterior ventilation. DHU gradients in these 2 axes were used to understand the determinants of clinical VH measurements derived from IOS and MBW.
There were no significant differences in values of the VH markers R5-R20 and S acin across GINA treatment intensity groups. Of the 3 of 41 asthmatic patients with a smoking history of more than 15 pack years, all had a PRM emphysema (PRM Emph ) score that was less than the mean 1 1.96 SD (5% PRM Emph ) in a healthy agematched population of 98 subjects 38 and preserved carbon monoxide transfer coefficient percent predicted values (Table I) . The 3 patients all had evidence of asthma objectively (1 had 78% FEV 1 reversibility, 1 had a PC 20 methacholine value of 2 mg/ mL, and 1 had 49% FEV 1 reversibility). Furthermore, of these 3 patients, only 2 demonstrated a postbronchodilator FEV 1 /FVC ratio of less than the lower limit of normal (63% of predicted value in both patients, respectively, with a postbronchodilator FEV 1 percentage of 72% and 57%, respectively).
Imaging biomarkers of global lung VH are not associated with values of the small-airway VH markers R5-R20 and S acin Table E1 outlines the formal definition of all of the CT scanderived imaging biomarkers. Table E2 in this article's Online Repository at www.jacionline.org presents comparisons of the global and regional imaging biomarkers, comparing asthmatic and healthy cases across the spectrum of GINA treatment intensity.
Asthmatic patients demonstrated significantly smaller PRM ellipse major diameters and smaller ellipse angles and had narrower distributions (SDs) of voxel HU change from FRC-TLC (P < .05) when compared with control subjects, which is indicative of less overall VH. Asthmatic patients did not differ from control subjects with respect to standard PRM markers (PRM Norm , PRM fSAD , and PRM Emph ; see Table E2 ). In contrast, patients who demonstrated FEV 1 /FVC ratios (percentages) of less than the median population value (primarily asthmatic patients) had higher levels of PRM fSAD and smaller PRM global ellipse areas (suggestive of less global heterogeneity) when compared with patients with FEV 1 /FVC ratios (percentages) of greater than or equal to the median value (P < .05; Fig 1, B and C) . These observations were not replicated with the small-airway indices of VH R5-R20 and S acin (see Fig E3 in this article's Online Repository at www.jacionline. org) and indicate that global PRM indices in the lung track with spirometry-defined airflow obstruction in contrast to smallairway physiologic indices.
Imaging biomarkers of regional VH are major determinants of the small-airway VH markers R5-R20 and S acin The population was split into low/high subgroups (low < _ mean and high > mean) according to absolute S acin and R5-R20 values to evaluate the relationship between regional imaging measures and small-airways physiology. Table II and Tables E3 (clinical  features) and E4 (imaging markers) in this article's Online Repository at www.jacionline.org summarize clinical and imaging features according to this stratification. Healthy cases predominated in the groups with low S acin (9/11) and low R5-R20 (8/11) values and asthmatic patients in the groups with high values.
Regional analysis identified that the gradient markers evaluating inferior-superior axis FRC-TLC deformation (DHU IS and DHU ISÃ ) slopes were the only markers that differed significantly in patients in the upper tertile of S acin and R5-R20 values when compared with the lower tertile (P < .05, Table II ). Specifically for patients with both high S acin and R5-R20 values, the ventilation gradient was reversed in the inferior-superior axis (DHU IS and DHU ISÃ ), such that ventilation was significantly reduced at the base of the lung. This is further exemplified in Further examination (Fig 4) of the distribution of DHU and regional PRM fSAD in cases with high and low DHU ISÃ values identified that patients with high DHU ISÃ (ventilation gradient reversal) values appeared to have focused regionalization of lung disease (particularly but not exclusively in the lower lobes). In contrast, patients with a low DHU ISÃ value had more homogeneous distributions of both DHU and PRM FSAD . Fifteen of 16 cases with high DHU ISÃ values had abnormal regional ventilation in contrast to 5 of 16 cases with low DHU ISÃ values. Regionalization of disease in all of these cases was in the lower lobes, generally focused at lung bases (see arrows). A x 2 analysis of the proportions of cases with abnormal regionalization in each group demonstrated a P value of less than .0001. DHU and PRM classifications correlated imperfectly (Fig 4) ; however, lower DHU voxels were consistently associated with PRM fSAD (see Fig E5 in this article's Online Repository at www.jacionline.org).
Imaging gradient biomarkers and clinical disease
We examined the relationship between the imaging gradient biomarkers and clinical disease expression (Table II, see Tables  E5-E7 in this article's Online Repository at www.jacionline.org). We found that anterior posterior gradient imaging biomarker std(DHU) AP correlated significantly with both 6-item Juniper Asthma Control Questionnaire (r 5 0.33, P 5 .039) and standard 32-question Juniper Asthma Quality of Life Questionnaire (r 5 20.34, P 5 .02) scores. We also found a significant association for the inferior-superior gradient imaging biomarker (DHU ISÃ ) and asthma-related quality of life (r 5 20.39, P < .01) but not asthma control. None of the gradient biomarkers were associated with exacerbation frequency.
Discrimination of S acin and R5-R20 with imaging markers of density change (DHU) gradients and lung size asymmetry Tables E8 and E9 in this article's Online Repository at www.jacionline.org present the results of LDA, which was used to identify the relative contribution of spatial CT-derived VH biomarkers, potential clinical contributors/confounders, and spirometry to the physiologic VH indices S acin and R5-R20. LDA demonstrated that the CT markers of DHU in the inferiorsuperior and anterior-posterior axes, as well as right to left lung size asymmetry, provided the greatest overall discriminatory value of small-airways physiologic indices, confirming that these metrics contained most of the information content of the clinical small-airways physiologic indices.
Computational modeling validation of CT imaging PRM gradients
Computational modeling of regional bronchoconstriction in small-airway patient-specific conducting airway models ( Fig 6) identified that increasing constriction of the small airways (< _2 mm diameter), which would be most influenced by gravity in the supine posture (lower lobe and posterior), promoted profound increases in R5-R20 values that were not seen with orthostatic simulations (ie, constriction of small airways that would be most influenced by gravity in the orthostatic posture). Furthermore, similar regional constriction in the upper lobes did not Inferior-superior DHU gradient analysis in patients with high/low S acin and R5-R20 values. A, Decilewise comparison of DHU mean differences in the inferior-to-superior direction of groups formed from the lower and upper tertiles of S acin and R5-R20 distributions, specifically the lowest and highest 16 subjects with respect to these 2 markers. The inferior regions show significant differences when comparing lower and upper tertiles for both S acin and R5-R20 values. B, Joint density histogram of voxel mean DHU and PRM fSAD percentages when projected onto the coronal plane in subjects showing the typical (healthy) ventilation (surrogated by DHU) pattern and homogenous PRM fSAD . C, As in Fig 3, B , but in a subject with an abnormal ventilation pattern and basally focused PRM fSAD . Color bars labeled with minimums and maximums of mean values. D, Concept of the inferior-superior gradient reversal phenotype is summarized in a simple visual schematic. promote the same difference on R5-R20 values when considering orthostatic and supine postures. Therefore the computational models provided further insight into associations between the lower-lobe regional focus of disease and R5-R20 response seen in the clinical imaging study (Figs 3 and 4) .
DISCUSSION
We performed the first quantitative functional CT imaging study to understand the spatial determinant of the small-airway VH markers R5-R20 and S acin in adult asthmatic patients and healthy volunteers. Furthermore, we have coupled CT imaging with computational simulation of small-airway physiology to understand the effect of the disease's regional pattern on abnormal physiologic indices of VH.
Using a panel of imaging biomarkers (Table E1 ) derived from inspiratory and expiratory CT scans, we have identified that gradients in DHU from the base to apex of the lung are key determinants of both physiologic measurements. Notably, there is a reversal of the normal ventilation gradient in this axis, such that DHU is reduced at the base of the lung in patients with asthma and indeed occasionally in healthy volunteers with abnormal S acin and R5-R20 values. In addition, we have identified that other mechanisms, including anterior-posterior DHU gradient decrease and other nonspecific regionalization of DHU might underpin abnormal R5-R20 and S acin indices in adult asthmatic patients. We found broadly similar but not identical results with the widely reported markers of small-airways disease PRM fSAD values. Computational small-airway tree models were then used to confirm the effect of gravitationally dependent lower-lobe disease regional focus on the IOS marker R5-R20 and matched our observation closely.
Previous studies have examined the difference in VH between asthmatic patients and healthy subjects by using hyperpolarized helium-3 MRI, 3 and another linked hyperpolarized helium-3 MRI with computational models to examine airway constriction in asthmatic patients. 39 We are also aware of one study in patient with bronchiectasis that attempted to correlate the global burden of CT-determined disease with physiologic indices of VH. 40 This study used correlations and regressions to identify associations between MBW Lung Clearance Index scores (a global marker of VH) and CT scores of the extent of bronchiectasis.
Our study uses quantitative functional CT-derived indices and specifically sheds insight into the topographical origins of abnormal R5-R20 (IOS-derived) and S acin (MBW-derived) VH markers. Furthermore, our observations, coupled with computer simulations (Figs 3, 4 , and 6) suggest that regionalization rather than global disease burden might be key determinants of S acin and R5-R20 in asthmatic patients.
Our results are clinically important for a number of reasons. Reduced basal ventilation in asthmatic patients can be associated with reduced effective deposition of inhaled drugs, which might be a factor in the poor asthma control reported in patients receiving inhaled corticosteroid/long-acting b-agonist combination therapies in European and other populations 41 ; this hypothesis would require testing with future studies. Additionally, our findings are important because they are the first to use spatial and functional information derived from quantitative PRMbased CT imaging to shed insight into empiric lung physiologic measurements R5-R20 and S acin , which are widely reported as small-airway dysfunction detection tools.
Interestingly, we found few differences in the PRM whole-lung averages for patients with fSAD, patients with emphysema, and healthy subjects (normally deforming lung voxels) in those with and without high levels of clinical VH derived from MBW and IOS. In contrast, average whole-lung PRM values were associated with airflow obstruction measured by using spirometry. The latter observations highlight both the importance of using the full information content of spatial imaging when trying to understand the topographical basis of VH indices and the fact that expiratory flow limitation in asthma is a maker of total burden of lung unit damage rather than the heterogeneity of damage.
A likely factor of the observed ventilation gradients in the lung is the ''slinky'' effect, which describes the compression of a slinky coil parallel to the gravitational field under normal gravitational conditions, isogravity, and hypergravity. 42 Because the dependent regions of the lung are compressed by the weight of the lung above them, they have lower end-expiratory volume, and the surrounding pleural pressure is more positive (in comparison with the apex); consequently, a given respiratory effort and change in pleural pressure will lead to a larger increase in volume.
Other factors responsible for ventilation and perfusion gradients are likely to include lung elastic recoil, nonlinear pressurevolume relationships, the influence of large vessels, and airway closure within dependent airways. These effects have been reported in imaging studies using both protocol MRI approaches 43 and, more recently, a CT imaging lung deformation study in patients with severe asthma. 19 The finding of a reverse DHU gradient at the base of the lung in patients with abnormal S acin and R5-R20 values and asthma can occur as a consequence of a number of factors in asthmatic patients. Specifically, basal airways can close at FRC in asthmatic patients, particularly when supine, and this can reduce the specific ventilation to the lung base; one study observed results to this effect in airway constriction because of methacholine challenge. 44 Additionally, the average BMI in our cohort was 30 kg/m 2 ; fat distribution in the abdomen and near the base of the lung can alter diaphragmatic and basal airway mechanics and promote airways closure. Additionally, it is possible that there is preferential remodeling of the airways in the lung base in asthmatic patients. However, this would need to be confirmed by pathologic studies. Similar effects, including the effect of gravity, can promote the smaller anterior-posterior gradient decrease seen in patients with clinical VH. It is important to note that LDA identified that ventilation gradients were the best discriminant of R5-R20 independent of potential confounders, such as BMI, smoking, and age.
The current findings in this report add to our previous observations that have identified that both the degree and heterogeneity of small-airway obstruction promote abnormal R5-R20 values 45 and that S acin can be driven by asymmetries in the lung at length scales that equate to the level of the alveolar duct. 9 Specifically, here we show that ventilation gradients in the lung are a major discriminant factor associated with both abnormal IOSderived R5-R20 and MBW-derived S acin values.
There are a number of limitations to our findings that warrant further evaluation. First, our study included asthmatic patients with a smoking pack year history of more than 15 pack years. Although these patients had no demonstrable imaging or physiologic evidence of emphysema, it is possible that smoking exposure rather than asthma per se was the driver of disease gradients in these patients. As a consequence, larger studies are required to evaluate the gradient biomarkers reported here across the spectrum of asthma severity and treatment intensity and in both smoking and nonsmoking asthmatic populations. The same limitation of sample size warrants further evaluation of the imaging biomarkers in populations of patients with severe asthma considering the association of the biomarkers with patient-related outcome measures in asthmatic patients. Such studies are underway and will be reported in due course. 46 Our imaging gradient biomarkers (derived through image registration of inspiratory and expiratory CT scans) are likely to be sensitive to both reconstruction kernel and lung volumes, as reported previously. 47 However, all of our CT scans were acquired at a single center with the same reconstruction kernel, and all patients were coached to expire to FRC for expiratory CT imaging before scanning. Nonetheless, it is possible that expiratory imaging near residual volume would accentuate the imaging findings observed here, and future studies are required to assess the effect of expiratory volume on the imaging biomarkers reported here.
In conclusion, we have shown, for the first time using functional and computational approaches derived from CT imaging, that small-airway VH captured by IOS-derived R5-R20 and MBW-derived S acin values is associated with CT density gradient reversal at the lung base, which is likely to be a direct consequence of reduced specific ventilation and small-airways disease. The implications of these findings on clinical disease expression, inhaled drug deposition, and potential use in targeted FIG 6. Comparison of R5-R20 values under varying regional small-airway constrictions applied to healthy lung structure. The R5-R20 response can be seen for homogeneous (A and C) and heterogeneous (B and D) constriction of the small airways. In each case constrictions were applied to the lowest or highest 25% of airways relative to the orthostatic or supine position. It can be seen that lower zone constriction and regionalization produce far greater increases in R5-R20 values than upper lobe constriction and regionalization, which is in keeping with the observations in Figs 3 and 4. inhaled drug delivery systems should now be considered in larger imaging cohorts and interventional studies.
Clinical implications: Asthmatic patients with abnormal smallairways VH measurements demonstrated small-airways disease and reduced ventilation in the inferior regions of the lung, which might affect the effectiveness of inhaled therapies.
